The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Subscribe To Our Newsletter & Stay Updated
